Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2017 / Cilt: 51 - Sayı: 1

Mucocutaneous findings in pediatric patients with bone marrow transplantation

Kemik iliği transplantasyonu yapılan pediyatrik olgularda mukokutanöz bulgular

Pages
7–11
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Close monitoring of dermatological signs is important to minimize the complications of the treatment in this patient group

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Bone marrow transplantation (BMT) is performed for many malign and non-malign diseases in pediatric patients.
📊
Key Findings & Data:In this study, it is aimed to define mucocutaneous changes in pediatric patients with BMT.Materials and Methods: A total of 44 patients, in whom BMT was planned between 2010 and 2011, were included in the study.
💡
Conclusion & Impact:Close monitoring of dermatological signs is important to minimize the complications of the treatment in this patient group
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Background and Design: Bone marrow transplantation (BMT) is performed for many malign and non-malign diseases in pediatric patients. Cutaneous signs in transplant patients are usually encountered in the presence of underlying primary diseases or due to the intense conditioning regimens that include chemotherapy and radiotherapy protocols. In this study, it is aimed to define mucocutaneous changes in pediatric patients with BMT.Materials and Methods: A total of 44 patients, in whom BMT was planned between 2010 and 2011, were included in the study. Dermatological examinations were performed at the beginning of the study and were repeated once a week in the first month, once a month in the following 5 months; and once in every 3 months in the last 1.5 years of follow-up.Results: Forty-one patients were completed the study. The mean age of 41 patients was 9.24 years (range: 1-17 years). Of the subjects, 26 (64%) were male and 15 (36%) were female. Dermatological signs, in order of frequency, were mucositis (75.6%), xeroderma (70.7%), alopecia (46.3%), nail disorders (24.3%), inflammatory skin diseases (24.2%), aphthous stomatitis (22%), cutaneous hyperpigmentation (22%), graft versus host diseases (17.1%), infectious diseases (15.5%), and maculopapular rash (4.8%).Conclusion: Dermatological diseases can be frequently observed in BMT patients. Close monitoring of dermatological signs is important to minimize the complications of the treatment in this patient group

Özet

Amaç: Kemik iliği transplantasyonu (KİT), pediyatrik hastalarda birçok malign ve malign olmayan hastalıkta kullanılmaktadır. Transplantasyon yapılan hastalarda gözlenen deri belirtileri, genellikle altta yatan primer hastalığa ya da uygulanan yoğun kemoterapi ve radyoterapi protokollerine bağlı olarak ortaya çıkmaktadır. Bu çalışmada, KİT yapılan pediyatrik olgularda mukokutanöz lezyonların tanımlanması amaçlanmıştır. Gereç ve Yöntem: Çalışmaya 2010-2011 yılları arasında KİT yapılması planlanan toplam 44 hasta dahil edilmiştir. Olguların ilk dermatolojik muayeneleri yapıldıktan sonra ilk ay içerisinde her hafta, takip eden 5 aylık süreçte ayda bir ve son 1,5 yılda ise her 3 ayda bir dermatolojik muayeneleri tekrarlanmıştır.Bulgular: Kırk bir olgu çalışmayı tamamladı. Toplam 41 olgunun yaş ortalaması 9,24 (minimum=1 yaş, maksimum=17 yaş); hastaların 26'sı (%64) erkek, 15'i (%36) kadındır. Görülme sıklığı oranlarına göre dermatolojik belirtiler mukozit (%75,6), kseroderma (%70,7), alopesi (%46,3), aftöz stomatit (%22), kutanöz hiperpigmentasyon (%22), tırnak bozuklukları (%24,3), enflamatuvar deri hastalıkları (%24,2), enfeksiyöz hastalıklar (%15,5), graft versus host hastalığı (%17,1) ve makülopapüler döküntü (%4,8) şeklinde sıralanmıştır. Sonuç: KİT hastalarında dermatolojik hastalıklar sıklıkla görülebilmektedir. Dermatolojik belirtilerin yakın takibi bu hasta grubunda tedavinin komplikasyonlarını azaltmada önemlidir

🔖

Cite This Article

CEYLAN, C., KANSOY, S., AKSOYLAR, S., TUNA, A., ÇETİNGÜL, N., KANTAR, M., GÜNAYDIN, A. (2022). Mucocutaneous findings in pediatric patients with bone marrow transplantation. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 51 - Sayı: 1, 7–11. https://ajindex.com/articles/621714

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Manzoni APDS, Kruse RL, Troian C, et al: Skin changes in pediatric transplant patients. Pediatr Transplant 2006;10:210-4
  2. Kamil N, Kamil S, Ahmed SP, et al: Toxic effects of multiple anticancer drugs on skin. Pak J Pharm Sci 2010;23:7-14
  3. Cardoza-Torres MA, Liy-Wong C, Welsh O, et al: Skin manifestations associated with chemotherapy in children with hematologic malignancies. Pediatr Dermatol 2012;29:264-9
  4. Seçkin D: Cutaneous lymphoproliferative disorders in organ transplant recipients: update 2014. G Ital Dermatol Venereol 2014;149:401-8
  5. Otmani N, Alami R, Hessissen L, et al: Determinants of severe oral mucositis in pediatric cancer patients: a prospective study. Int J Pediatr Dent 2011;21:210-6
  6. Huang V, Anadkat M: Dermatologic manifestations of cytotoxic therapy. Dermatol Ther 2011;24:401-10
  7. Urbain P, Raynor A, Bertz H, et al: Role of antioxidants in buccal mucosa cells and plasma on the incidence and severity of oral mucositis after allogeneic haematopoietic cell transplantation. Support Care Cancer 2012;20:1831-8
  8. Eduardo F de P, Bezinelli LM, de Carvalho DL, et al: Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: Clinical outcomes in a context of specialized oral care using low-level laser therapy. Pediatr Transplant 2015;19:316-25
  9. Lalla RV, Gordon GB, Schubert M, et al: A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to highdose chemotherapy. Support Care Cancer 2012;20:1797-804
  10. Guhl G, Torrelo A, Hernandez A, Zambrano A: Beau’s lines and multiple periungual pyogenic granulomas after long stay in an intensive care unit. Pediatr Dermatol 2008;25:278-9
  11. O'branski EE, Ware RE, Prose NS, Kinney TR: Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy. J Am Acad Dermatol 2001;44:859-61
  12. Byun HJ, Yang JI, Kim BK, Cho KH: Clinical differentiation of acute cutaneous graft versus host disease from drug hypersensitivity reactions. J Am Acad Dermatol 2011;65:726-32
  13. İnalöz S: Liken planus ve likenoid erüpsiyonlar. Dermatoloji. Ed. Tüzün Y, Gürer MA, Serdaroğlu S, Oğuz O, Aksungur VL: 3. baskı. İstanbul, Nobel Tıp Kitabevleri, 2008;794-5
  14. Alley E, Green R, Schuchter L: Cutaneous toxicities of cancer therapy. Curr Opin Oncol 2002;14:212-6
  15. Rau R, Fitzhugh CD, Baird K, et al: Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella zoster v